CTRI/2021/10/037286已完成3 期
A PROSPECTIVE, OPEN LABEL, RANDOMIZED, CONTROLLED STUDY TO ASSESS THE CLINICAL EFFICACY OF MULMINA-D MANGO (READY TO DRINK) INIMPROVING THE OVERALL GENERAL WELL-BEING IN GERIATRIC POPULATION.
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •i. Individual is at least 55 years old but not older than 85 years
- •ii. Diabetic subjects who are non-insulin dependent (NIDD)
- •iii. Individual is not simultaneously enrolled in another program promoting either well-being or physical activity
- •iv. Individual is with mild to moderate hypertensive, diabetic or other co-morbidities that are of no immediate life threatening to the volunteer
- •v. Subjects willing to refrain from using any external supplements like Vitamins and Minerals during the trial period.
排除标准
- •i. Pregnancy or breast feeding.
- •ii. Evidence of significant uncontrolled co-morbid diseases which in the investigators opinion would jeopardize patient participation.
- •iii. History of cancer, including solid tumors, hematologic malignancies and carcinoma in situ.
- •iv. Any neurological congenital or acquired vascular or systemic disorder which could affect any of the efficacy assessments.
- •v. Participation in the current or previous treatment with any approved or investigational health supplements during the past 1 month.
研究者
相似试验
招募中
4 期
A RANDOMIZED, CONTROLLED, OPEN-LABEL, SINGLE-CENTER, PARALLEL GROUP STUDY TO ASSESS THE EFFECT OF MIRCERA ON DELAYING DIALYSIS IN ANEMIC PATIENTS WITH STAGE 5 CHRONIC KIDNEY DISEASE NOT ON DIALYSIScardiovascular events,stroke,myocardial infarction,leg amputation,admission by heart failure or angina.TCTR20190718006Department of Nephrology Unit Faculty of Medicine Chulalongkorn University200
进行中（未招募）
1 期
Study to assess efficacy of angiotensin converting enzyme inhibitors on mortality and cardiovascular morbidity in patients on chronic hemodialysis, with ventricular hypertrophy and / or hypertensioEnd stage renal diseaseMedDRA version: 14.1Level: PTClassification code 10029151Term: NephropathySystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2008-003529-17-ITIST. DI RICERCHE FARMACOLOG. M. NEGRI269
撤回
3 期
A PROSPECTIVE, RANDOMIZED, OPEN-LABEL, BLINDED ENDPOINT EVALUATION (PROBE) PARALLEL GROUP STUDY COMPARING EDOXABAN VS. VKA IN SUBJECTS UNDERGOING CATHETER ABLATION OF NON-VALVULAR ATRIAL FIBRILLATIOatrial fibrillationNL-OMON45248Daiichi Pharmaceutical25
尚未招募
不适用
EFFECT OF DENOSUMAB IN POST-RENAL TRANSPLANT RECIPIENT WITH OSTEOPOROSIS VS PLACEBO- AN OPEN LABELLED PROSPECTIVE RANDOMIZED CONTROLLED TRIAL.CTRI/2022/09/045397IPGMER AND SSKM HOSPITAL KOLKATA
进行中（未招募）
不适用
Clinical trial designed to compare the metabolic effects of Telmisartan compared with Losartan in patients with renal transplantatioEUCTR2008-000822-38-ITIST. DI RICERCHE FARMACOLOG. M. NEGRI